This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
|Zacks Rank||Definition||Annualized Return|
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank
Aetna, Inc. (AET)
by Zacks Equity ResearchApril 10, 2012 | Comments : 0 Recommended this article: (0)
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at email@example.com or call 800-767-3771 ext. 9339.
The company ended the year 2011 with better performances, demonstrating growth in membership, revenues, operating margins and cash flow on the back of low medical utilization, pricing discipline, medical cost management strategies and cost controls. In 2011, the company made strategic investments in acquisitions and technologies, with the intent to extend its core health business and also to capitalize on exciting new consumer as well as provider opportunities emerging in the marketplace.
Aetna's strong operating results and significant capital generation will allow it to continue investing for the future. We expect the company to keep performing better in 2012. The Zacks Consensus estimates earnings of $1.39 per share for first quarter 2012, which translates into an expected earnings growth of 10.5% year over year.
Please login to Zacks.com or register to post a comment.